HEAD START 4: NEWLY DIAGNOSED CHILDREN (LESS THAN 10 YEARS OLD) WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS

Go Back to All Clinical Trials

HEAD START 4: NEWLY DIAGNOSED CHILDREN (LESS THAN 10 YEARS OLD) WITH MEDULLOBLASTOMA AND OTHER CENTRAL NERVOUS SYSTEM EMBRYONAL TUMORS

Brief description of study

If your child has been diagnosed with medulloblastoma or other central nervous system embryonal tumors, your child may qualify to participate in a study. The main goal of this randomized trial is to compare single consolidation versus tandem (3 cycles) consolidation regimen provides the same outcome. Also this study will determine if through the reduction of chemotherapy cycles, results in lower long term toxicities, in particular ototoxicity.

Clinical Study Identifier: s17-00351

ClinicalTrials.gov Identifier: NCT02875314

Principal Investigators: Sharon L Gardner, iConnect Langone.

Other Investigator: Jessica Clymer.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies